The COVID-19 pandemic shook the world, and forced scientists to develop a vaccine rapidly, foregoing all normal protocol. Post-Market Surveillance of adverse events became a critical element of the ongoing development of vaccines.
This article looks more closely at how the VAERS (Vaccine Adverse Event Reporting System) tracks how professionals and the public are reacting to these vaccines. VAERS is a publicly accessible database that provides post-market complaint data and can contribute to an evaluation of a risk/benefit profile for the different vaccines. Access the article, which includes a sample of the literature review results, here.